Cutler Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1546 |
|
|
2023
Q4 | – | Sell |
-10,620
| Closed | -$88K | – | 1768 |
|
|
2023
Q3 | $88K | Buy |
10,620
+10,500
| +8,750% | +$87K | 0.01% | 586 |
|
|
2023
Q2 | $1K | Buy |
120
+11
| +10% | +$92 | ﹤0.01% | 1307 |
|
|
2023
Q1 | $1K | Sell |
109
-14,802
| -99% | -$136K | ﹤0.01% | 1339 |
|
|
2022
Q4 | $121K | Buy |
14,911
+2,274
| +18% | +$18.5K | 0.01% | 565 |
|
|
2022
Q3 | $73K | Sell |
12,637
-289
| -2% | -$1.67K | 0.01% | 769 |
|
|
2022
Q2 | $57K | Buy |
12,926
+1,392
| +12% | +$6.14K | ﹤0.01% | 841 |
|
|
2022
Q1 | $104K | Buy |
11,534
+1,520
| +15% | +$13.7K | 0.01% | 799 |
|
|
2021
Q4 | $204K | Buy |
+10,014
| New | +$204K | 0.01% | 683 |
|
|
2021
Q3 | – | Sell |
-2,000
| Closed | -$69K | – | 2567 |
|
|
2021
Q2 | $69K | Sell |
2,000
-36,504
| -95% | -$1.26M | ﹤0.01% | 1133 |
|
|
2021
Q1 | $1.28M | Buy |
38,504
+38,404
| +38,404% | +$1.28M | 0.06% | 211 |
|
|
2020
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1657 |
|
|
2017
Q3 | – | Sell |
-12,598
| Closed | -$44K | – | 2917 |
|
|
2017
Q2 | $44K | Buy |
12,598
+7,127
| +130% | +$24.9K | ﹤0.01% | 1531 |
|
|
2017
Q1 | $28K | Sell |
5,471
-8,625
| -61% | -$44.1K | ﹤0.01% | 1749 |
|
|
2016
Q4 | $53K | Sell |
14,096
-33,391
| -70% | -$126K | ﹤0.01% | 1482 |
|
|
2016
Q3 | $425K | Sell |
47,487
-4,000
| -8% | -$35.8K | 0.02% | 437 |
|
|
2016
Q2 | $362K | Buy |
51,487
+37,571
| +270% | +$264K | 0.02% | 485 |
|
|
2016
Q1 | $118K | Buy |
13,916
+10,716
| +335% | +$90.9K | 0.01% | 852 |
|
|
2015
Q4 | $42K | Buy |
+3,200
| New | +$42K | ﹤0.01% | 1497 |
|